OraSure Technologies stock sits above its USD 3.00 consensus target

Published on 10/17/2026 at 18:37 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Revenue is USD 31.14 million for November 4, 2026. OraSure Technologies stock cost USD 3.61 on October 16, 2026, down 5.25 percent versus prior close.

Target and revenue outlook

A USD 3.00 consensus target was reported for OraSure Technologies on October 15, 2026.
Expected revenue for November 4, 2026 stands at USD 31.14 million.
OraSure Technologies stock cost USD 3.61 at Nasdaq on October 16, 2026 at 4:00 p.m. ET, down 5.25 percent versus the prior close.
Market capitalization stood at USD 249.0 million, with a negative P/E ratio of -5.23.

OSUR, US68554V1089, Illustration mit AI erstellt.

OraSure Technologies stock sits above a USD 3.00 consensus target, with MarketBeat reporting the average target on October 15, 2026. The USD 3.61 Nasdaq closing price on October 16, 2026 at 4:00 p.m. ET was down 5.25 percent versus the prior close.

Revenue estimate for November 4

The next scheduled reporting date is November 4, 2026. MarketBeat lists expected third-quarter revenue of USD 31.14 million and adjusted earnings per share of minus USD 0.18. The company is expected to report after the US market closes, with a conference call scheduled for 5:00 p.m. ET.

Price sits below the yearly high

The October 16 Nasdaq range ran from USD 3.61 to USD 3.83, while volume reached 317,868 shares against an average of 494,275. The 52-week range was USD 2.08 to USD 4.58, placing the closing price 21.18 percent below the high and 73.56 percent above the low. Year to date, the stock was down 49.17 percent.

Valuation and reporting date

OraSure Technologies had a market capitalization of USD 249.0 million as of October 16, 2026, and a P/E ratio of -5.23. The average target of USD 3.00 sits 16.90 percent below the closing price of USD 3.61. MarketBeat describes the consensus as Reduce, based on two Hold ratings and one Sell rating.

Comparison with peers

OSUR (Nasdaq, USD): minus 5.25 percent, P/E -5.23, market capitalization USD 249.0 million

LENSAR (Nasdaq, USD): minus 3.81 percent, P/E -17.58, market capitalization USD 71.3 million

QuidelOrtho (Nasdaq, USD): minus 7.19 percent, P/E -0.84, market capitalization USD 885.3 million

Price and the next report

The November 4 reporting date gives the next clear calendar point, while the USD 3.00 consensus target remains below the October 16 Nasdaq close. OraSure Technologies develops diagnostic tests and molecular collection products for clinical, consumer and research customers.

OraSure Technologies stock last stood at USD 3.61 on Nasdaq on October 16, 2026 at 4:00 p.m. ET, down 5.25 percent versus the prior close.